Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
GFT Technologies AG

Start price
Target price
Perf. (%)
€39.45
06.12.21
€43.50
06.12.22
-12.29%
07.12.22

Could be worthwhile Investment >10% per year
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€5.22
05.12.21
€2.70
05.12.22
-44.67%
16.03.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
SPI Energy Co Ltd ADR

Start price
Target price
Perf. (%)
€3.87
05.12.21
€1.90
05.12.22
-24.28%
16.03.22

Valuable balance sheet
Capable Management
Sustainability is not important
ROE lower than 10% per year
Baozun Inc ADR

Start price
Target price
Perf. (%)
€11.75
05.12.21
€4.00
05.12.22
-40.26%
16.03.22

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
buy
Nordex SE

Start price
Target price
Perf. (%)
€14.95
05.12.21
-
05.12.22
-5.42%
23.12.21

buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€13.05
05.12.21
-
05.12.22
-48.66%
11.12.21

Risky Investment
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.88
05.12.21
-
05.12.22
0.47%
12.12.21

Risky Investment
buy
Group 1 Automotive

Start price
Target price
Perf. (%)
€179.00
05.12.21
-
05.12.22
0.56%
06.12.22

Could be worthwhile Investment >10% per year
buy
Dürr AG

Start price
Target price
Perf. (%)
€37.44
05.12.21
€44.00
05.12.22
-11.32%
06.12.22

Could be worthwhile Investment >10% per year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€147.98
05.12.21
-
05.12.22
-23.17%
07.01.22

Could be worthwhile Investment >10% per year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€42.42
03.12.21
-
03.12.22
7.50%
11.12.21

Risky Investment
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.62
03.12.21
-
03.12.22
0.84%
11.12.21

Could be worthwhile Investment >10% per year
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.28
02.12.21
-
02.12.22
-0.61%
11.12.21

Risky Investment
buy
Prodways Group

Start price
Target price
Perf. (%)
€2.92
01.12.21
€3.20
01.12.22
35.27%
02.12.22

Could be worthwhile Investment >10% per year
buy
Lannett Co. Inc.

Start price
Target price
Perf. (%)
€5.88
01.12.21
-
01.12.22
-61.58%
02.12.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Revenue growth > 30% per year expected
High Investments for future growth
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€4.85
01.12.21
-
01.12.22
-53.67%
02.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€14.52
01.12.21
-
01.12.22
-11.23%
11.12.21

Could be very worthwhile Investment >20% year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.96
01.12.21
€6.00
01.12.22
-2.70%
11.12.21

Could be worthwhile Investment >10% per year
Innovative
Good culture
Below average Management
buy
BioXcel Therapeutics Inc

Start price
Target price
Perf. (%)
€17.00
01.12.21
-
01.12.22
16.71%
12.12.21

Risky Investment
Krystal Biotech

Start price
Target price
Perf. (%)
€66.00
01.12.21
€50.00
31.12.23
16.67%
08.05.23

Could be very worthwhile Investment >20% year
buy
Abivax S.A.

Start price
Target price
Perf. (%)
€25.50
01.12.21
€28.00
01.12.22
-31.92%
20.05.22

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
buy
MBB SE

Start price
Target price
Perf. (%)
€120.40
30.11.21
€135.00
30.11.22
13.12%
12.01.22

Standard Investments for future growth
Differentiated customer and product portfolio
Higher risks for its business
Significant cyclical dependencies
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€0.99
30.11.21
€1.00
30.11.22
36.36%
11.12.21

Could be very worthwhile Investment >20% year
Good culture
Innovative
Few uniques
buy
Focus Home Interactive SAS

Start price
Target price
Perf. (%)
€38.95
30.11.21
€50.00
30.11.22
18.49%
01.12.22

Could be worthwhile Investment >10% per year
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€39.25
30.11.21
-
30.11.22
-17.83%
12.12.21

Probably not worthwhile Investment